Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA.
about
Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum ComplexesPharmacodynamic model for chemotherapy-induced anemia in rats.Rapid cross-linking of an RNA internal loop by the anticancer drug cisplatinEffects of geometric isomerism and anions on the kinetics and mechanism of the stepwise formation of long-range DNA interstrand cross-links by dinuclear platinum antitumor complexes.Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacyUnusual DNA binding modes for metal anticancer complexes.Interaction of liposome-encapsulated cisplatin with biomolecules.Rates of intercalator-driven platination of DNA determined by a restriction enzyme cleavage inhibition assay.Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexesRationally engineered polymeric cisplatin nanoparticles for improved antitumor efficacyRationally designed oxaliplatin-nanoparticle for enhanced antitumor efficacyCholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicitySensitive Marker of the Cisplatin-DNA Interaction: X-Ray Photoelectron Spectroscopy of CL.Influence of reducing agents on the cytotoxic activity of platinum(IV) complexes: induction of G2/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines.Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.Reduction of some Pt(IV) complexes with biologically important sulfur-donor ligands.A systematic capillary electrophoresis study on the effect of the buffer composition on the reactivity of the anticancer drug cisplatin to the DNA model 2'-deoxyguanosine 5'-monophosphate (dGMP).The effect of the extracellular domain of human copper transporter (hCTR1) on cisplatin activation.Cisplatin Binding to Biological Ligands Revealed at the Encounter Complex Level by IR Action Spectroscopy.In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS.
P2860
Q24289008-7FD3F961-C002-4EEE-A815-005D03C8FC1AQ33376775-61626D30-B808-4428-8107-8811A7313184Q33476310-2336398C-615C-4DA8-B3C7-86E675E30969Q33675696-8DB2FDCF-76A6-43BB-91F6-F6F7D3BD1F64Q34005179-96D97FC1-05A1-43AC-8418-B7236C140051Q34071185-44A7FA8F-DE20-470C-98FC-1D391CA3CE19Q34295156-3343063D-F7FD-436D-B511-20736E736789Q34629768-3728E231-AF71-4E7E-8C3F-DD64244D06CFQ34731239-20D702F7-16C6-44C9-A44C-293D641BD521Q35173143-08BBF565-7800-449C-9FEF-ED8D300E4FA5Q36070256-B2DD1C23-08FE-4A00-9B5E-ABDF224592ECQ36094353-6A5D2D19-45D5-4130-BA95-507176AE3ECFQ36362182-B320B269-9CCA-4A49-9CFF-D3658CFD70D1Q38864172-1A2062F5-82EC-4D5B-ACF9-A2E339AB9D18Q39824889-146A7483-CE72-479D-8F2B-418CE698F546Q42874055-9A0B8E88-12B8-4D95-A2E2-4D21AFBF4819Q44280069-67747C26-20ED-471F-8A3C-F123AA460E4AQ44473824-D233EBD0-58C1-49BA-9C80-A483E3440CA5Q46456871-CA70E7F8-7F6C-4330-8217-60476F5659A7Q48265802-9796D206-384E-459E-A226-720AB149B26CQ53116557-C65A6A09-AA96-402A-8EB9-A4BB2C5A0CC3
P2860
Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Slowing of cisplatin aquation ...... e binding of cisplatin to DNA.
@ast
Slowing of cisplatin aquation ...... e binding of cisplatin to DNA.
@en
type
label
Slowing of cisplatin aquation ...... e binding of cisplatin to DNA.
@ast
Slowing of cisplatin aquation ...... e binding of cisplatin to DNA.
@en
prefLabel
Slowing of cisplatin aquation ...... e binding of cisplatin to DNA.
@ast
Slowing of cisplatin aquation ...... e binding of cisplatin to DNA.
@en
P2093
P356
P1433
P1476
Slowing of cisplatin aquation ...... e binding of cisplatin to DNA.
@en
P2093
Berners-Price SJ
Hambley TW
P304
P356
10.1021/IC000847W
P407
P577
2000-12-01T00:00:00Z